Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

NMDA antagonist neurotoxicity: mechanism and prevention.

Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA.

Science. 1991 Dec 6;254(5037):1515-8.

PMID:
1835799
2.

Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.

Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C.

Mol Psychiatry. 2002;7(1):32-43.

4.

[NMDA receptor antagonist neurotoxicity and psychotomimetic activity].

Nakao S, Nagata A, Masuzawa M, Miyamoto E, Yamada M, Nishizawa N, Shingu K.

Masui. 2003 Jun;52(6):594-602. Review. Japanese.

PMID:
12854473
5.
7.

L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.

Widdowson PS, Wyatt I, Gyte A, Simpson MG, Lock EA.

Toxicol Appl Pharmacol. 1996 Jan;136(1):138-45.

PMID:
8560467
8.
9.
10.

The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.

Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA.

Neurotoxicology. 1999 Aug;20(4):551-9.

PMID:
10499354
11.
12.

Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.

Clifford DB, Olney JW, Benz AM, Fuller TA, Zorumski CF.

Epilepsia. 1990 Jul-Aug;31(4):382-90.

PMID:
2196169
13.

Involvement of direct inhibition of NMDA receptors in the effects of sigma-receptor ligands on glutamate neurotoxicity in vitro.

Nishikawa H, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A.

Eur J Pharmacol. 2000 Sep 15;404(1-2):41-8.

PMID:
10980261
14.

Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.

McDonald JW, Silverstein FS, Cardona D, Hudson C, Chen R, Johnston MV.

Neuroscience. 1990;36(3):589-99.

15.
16.

[Role of excitatory amino acids in neuropathology].

Wikinski SI, Acosta GB.

Medicina (B Aires). 1995;55(4):355-65. Review. Spanish.

PMID:
8728878
17.

Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.

De Vry J, Jentzsch KR.

Behav Pharmacol. 2003 May;14(3):229-35.

PMID:
12799525
18.

[Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs].

Hashimoto K, Iyo M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Feb;22(1):3-13. Review. Japanese.

PMID:
11917507
19.

Intra-striatal phencyclidine inhibits N-methyl-D-aspartic acid-stimulated increase in glutamate levels of freely moving rats.

Yamamoto Y, Kakigi T, Maeda K.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Jan;23(1):161-74.

PMID:
10368862
20.

Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).

Vivian JA, Waters CA, Szeliga KT, Jordan K, Grant KA.

Psychopharmacology (Berl). 2002 Jul;162(3):273-81. Epub 2002 May 14.

PMID:
12122485

Supplemental Content

Support Center